Five-Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study

American Journal of Transplantation, 04/06/2012

Results confirmed the high sirolimus discontinuation rate due to adverse events. Nevertheless, a benefit was evidenced on renal function in patients still on treatment at 5 years.

Print Article Summary Cat 2 CME Report